Aster DM Healthcare Limited has informed the Exchange about General Updates
ASTERDM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aster DM Healthcare is providing an update on its proposed merger with Quality Care India Limited (backed by Blackstone) under Sections 230-232 of the Companies Act, 2013. The company has already secured 99.998% shareholder approval for the share swap, and a formal equity shareholders' meeting is scheduled for March 10, 2026 via video conferencing. The merged entity would become one of India's top 3 hospital chains, operating across 9 states and 25 cities with 6,690+ clinicians serving roughly 2 million patients per quarter. Identified synergies are expected to deliver an EBITDA upside of 10-15% of FY24 pro-forma EBITDA. The filing also addresses governance questions, confirming that Aster Promoters and Blackstone will waive board nomination rights once their shareholding falls below 10%, and that all board committees will retain mandatory independent director representation.
This is a positive update confirming strong shareholder backing and progress on what is described as the largest hospital-sector deal in India. Investors should watch the March 10 shareholder meeting and subsequent NCLT approvals; successful completion could drive long-term value through scale, geographic reach, and cost synergies, while the governance commitments (waiver of nomination rights at 10% shareholding) address minority shareholder concerns.